Sherbrooke Park Advisers’s Terns Pharmaceuticals TERN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-17,846	Closed	-$98.9K	–	927
2024 Q4	$98.9K	Buy	+17,846	New	+$98.9K	0.03%	672